Many patients with triple-negative breast cancer (TNBC), which lacks the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2), have a high death rate in Africa [3]. Here, ERBB2 is linked to triple-negative breast carcinoma.